Lymphedema Treatment Market Size & Share, Growth by 2028

Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type {Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures [Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)], Debulking Procedures [Surgical Debulking, Liposuction, and Others], and Others}, and End-User (Hospitals, Clinics, Clinical Research Organizations, and Others)

  • Report Code : TIPRE00026594
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 209
Buy Now

Lymphedema Treatment Market Size & Share, Growth by 2028

Buy Now

The lymphedema treatment market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 billion in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028.

Lymphedema is a condition in which the body enlarges abnormally due to the lymphostasis caused by lymphatic system dysfunction. It most commonly affects the lower extremity (90%), upper extremity (10%), and genitalia (1%). Primary lymphedema is present at birth whereas secondary lymphedema is caused by lymphatic system inefficiency or damage. The secondary lymphedema frequently develops after cancer treatment. Lymphedema is caused by obstructions in the passage of lymph fluid caused by surgery, radiation therapy, or cancer growth. The feelings of tightness or heaviness; swelling in legs, arms, or other body parts; aching or discomfort; and fibrosis, which thickens or hardens the skin, are among the common symptoms of lymphedema.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Lymphedema Treatment Market: Strategic Insights

lymphedema-treatment-market
Market Size Value inUS$ 8.15 billion in 2021
Market Size Value byUS$ 11.58 billion by 2028
Growth rateCAGR of 5.1% from 2021 to 2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst


The growth of the lymphedema treatment market is attributed to the growing incidence of lymphedema and increasing number of lymphedema management programs with a surge in the promotion of telehealth services in various countries. However, the lack of skilled professionals and high surgical costs in developing economies hamper the market growth.

Market Insights
Rising Cases of Lymphedema

According to the United States Department of Health and Human Services, lymphedema can occur in cancer patients upon the onset of the disease or after its treatment, which affect lymph node drainage. For example, it has been reported that it can occur within days and up to 30 years after the treatment for breast cancer. Also, 80% of patients experience onset within 3 years of surgery, and the remainder develops edema at a rate of 1% per year. Additionally, a large patient pool, particularly women, suffers from lower-limb lymphedema after the treatment of gynecologic cancer, with the highest prevalence (37%) among vulvar cancer survivors and lowest prevalence (7%) among ovarian cancer survivors. Further, the overall incidence of arm lymphedema ranges from 8% to 56% at two years post-surgery. The Alliance Z 1071 longitudinal substudy of the American College of Surgeons Oncology Group (ACOSOG) states that in breast cancer trials, patients report a 3-year cumulative incidence of arm swelling and arm heaviness. Highly effective and advanced cancer treatment options assist in minimizing the risk of lymphedema. Therefore, major players in the cancer therapeutics market are highly focused on launching innovative products.

Condition Type - Based Insights

Based on condition type, the global lymphedema treatment market has been segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held a larger share of the market in 2021. However, the primary lymphedema segment is anticipated to register a higher CAGR in the market during the forecast period. The current market growth of the secondary lymphedema segment is attributed to the fact that cancer treatment is a prominent cause of secondary lymphedema, and majority of people suffering from secondary lymphedema are high in the developing and developed countries.  

Treatment Type - Based Insights

Based on treatment type, the global lymphedema treatment market has been segmented into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Further, the debulking procedures segment is subsegmented as surgical debulking, liposuction, and others. The compression devices and bandaging segment accounted for the largest market share in 2021. Companies in the lymphedema treatment market are developing different types of compression garments and are promoting cost-effective products. Further, the physiological procedure segment is anticipated to register the highest CAGR in the market during the forecast period.

Lymphedema Treatment Market Report Scope

End-User - Based Insights

Based on end-user, the global lymphedema treatment market has been segmented into hospitals, clinics, clinical research organizations (CROs), and others (ambulatory care centers and primary care centers). The hospitals segment captured the largest market share in 2021. The clinics segment is expected to register the highest CAGR during the forecast period; the market growth of this segment can be ascribed to the fact that lymphedema treatments are mostly offered in specialized centers or units. Specialized surgical treatments such as liposuction and debulking procedures take place in specialty clinics that have a dedicated department for neurology, or more specifically, lymphedema treatment.

 

Product launches and approvals are commonly adopted strategies by companies in the lymphedema treatment market to expand their global footprints and product portfolios. Moreover, the market players focus on the partnership strategy to expand their clientele, which, in turn, allows them to maintain their brand name worldwide.


Company Profiles

  • BIOCOMPRESSION SYSTEMS
  • Tactile Medical
  • Smith & Nephew
  • BSN medical GmbH
  • Lohmann & Rauscher GmbH & Co. KG
  • SIGVARIS GROUP
  • ThermoTek
  • Huntleigh Healthcare Limited
  • 3M
  • Mego Afek ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Condition Type, Treatment Type, and End-User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

Frequently Asked Questions


Who are the key players in the Lymphedema Treatment market?

BIOCOMPRESSION SYSTEMS; Tactile Medical; Smith and Nephew; BSN Medical GmbH; Lohmann & Rauscher GmbH & Co. KG; SIGVARIS GROUP; ThermoTek; Huntleigh Healthcare Limited; 3M; Mego Afek Ltd. are among the key companies operating in the lymphedema treatment market.

What will be the CAGR of Lymphedema Treatment market?

The market is estimated to grow with a CAGR of 5.1% from 2021 to 2028.

What are the driving factors for the Lymphedema Treatment market across the NA, EU, APAC, SCAM, and MEA regions?

Key factors that are driving the growth of the market are increasing incidences of lymphedema and programs conducted by the government fuel the growth of the market.

What is Lymphedema Treatment?

Lymphedema treatment mainly refers to the treatment options that are used in combatting primary and secondary lymphedema disease conditions. Some of the treatment types that are considered in the process include laser therapy, debulking procedures, liposuction, lymph node transfer, compression, and bandaging devices.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Lymphedema Treatment Market – By Condition Type

1.3.2 Global Lymphedema Treatment Market – By Treatment Type

1.3.3 Global Lymphedema Treatment Market – By End-User

1.3.4 Global Lymphedema Treatment Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Lymphedema Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Lymphedema Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Lymphedema Cases

5.1.2 Increasing Healthcare Services and Lymphedema Management Programs

5.2 Market Restraints

5.2.1 Lack of Awareness and Skilled Professionals

5.3 Market Opportunities

5.3.1 Rising Treatment Options

5.4 Future Trends

5.4.1 Use of Robotics for Lymphedema Treatment

5.5 Impact Analysis

6. Lymphedema Treatment Market– Global Analysis

6.1 Global Lymphedema Treatment Market Revenue Forecast and Analysis

6.2 Global Lymphedema Treatment Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Lymphedema Treatment Market Revenue and Forecasts To 2028– by Condition Type

7.1 Overview

7.2 Global Lymphedema Treatment Market, By Condition Type, 2021 & 2028 (%)

7.3 Primary Lymphedema

7.3.1 Overview

7.3.2 Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Secondary Lymphedema

7.4.1 Overview

7.4.2 Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8. Global Lymphedema Treatment Market Revenue and Forecasts To 2028– by Treatment Type

8.1 Overview

8.2 Global Lymphedema Treatment Market, By Treatment Type, 2021 & 2028 (%)

8.3 Laser Therapy

8.3.1 Overview

8.3.2 Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Compression Devices and Bandaging

8.4.1 Overview

8.4.2 Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Drug Therapy

8.5.1 Overview

8.5.2 Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Physiological Procedures

8.6.1 Overview

8.6.2 Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.6.2.1 Lymphovenous Anastomosis (LVA)

8.6.2.1.1 Overview

8.6.2.1.2 Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.6.2.2 Vascularized Lymph Nodes Transfer (VLNT)

8.6.2.2.1 Overview

8.6.2.2.2 Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.7 Debulking Procedures

8.7.1 Overview

8.7.2 Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.7.2.1 Surgical Debulking

8.7.2.1.1 Overview

8.7.2.1.2 Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.7.2.2 Liposuction

8.7.2.2.1 Overview

8.7.2.2.2 Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.7.2.3 Others

8.7.2.3.1 Overview

8.7.2.3.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9. Global Lymphedema Treatment Market Revenue and Forecasts To 2028– by End-User

9.1 Overview

9.2 Global Lymphedema Treatment Market, By End-User, 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5 Clinical Research Organization (CRO’s)

9.5.1 Overview

9.5.2 Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10. North America Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Lymphedema Treatment Market

10.1.1 Overview

10.1.2 North America: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Lymphedema Treatment Market, by Condition Type, 2019–2028 (US$ Million)

10.1.4 North America: Lymphedema Treatment Market, by Treatment Type, 2019–2028 (US$ Million)

10.1.4.1 North America: Lymphedema Treatment Market, by Physiological Procedure, 2019–2028 (US$ Million)

10.1.4.2 North America: Lymphedema Treatment Market, by Debulking Procedure, 2019–2028 (US$ Million)

10.1.5 North America: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)

10.1.6 North America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Lymphedema Treatment Market– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 US: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2 US: Lymphedema Treatment Market, by Condition Type, 2019–2028 (US$ Million)

10.1.6.1.3 US Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3.1 US: Lymphedema Treatment Market, by Physiological Procedures, 2019–2028 (US$ Million)

10.1.6.1.3.2 US: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)

10.1.6.1.4 US: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)

10.1.6.2 Canada: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Canada: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2 Canada: Lymphedema Treatment Market, by Condition Type, 2019–2028 (US$ Million)

10.1.6.2.3 Canada: Lymphedema Treatment Market, by Non- Treatment Type, 2019–2028 (US$ Million)

10.1.6.2.3.1 Canada: Lymphedema Treatment Market, by Physiological Procedures, 2019–2028 (US$ Million)

10.1.6.2.3.2 Canada: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Mexico: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2 Mexico: Lymphedema Treatment Market, by Condition Type – 2019–2028 (US$ Million)

10.1.6.3.3 Mexico: Lymphedema Treatment Market, by Treatment Type – 2019–2028 (US$ Million)

10.1.6.3.3.1 Mexico: Lymphedema Treatment Market, by Physiological Procedures – 2019–2028 (US$ Million)

10.1.6.3.3.2 Mexico: Lymphedema Treatment Market, by Debulking Procedures, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Lymphedema Treatment Market, by End User, 2019–2028 (US$ Million)

10.2 Europe: Lymphedema Treatment Market

10.2.1 Overview

10.2.2 Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.4 Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.4.1 Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.4.2 Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.5 Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6 Europe: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4 Germany: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4.1 Germany: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.4.2 Germany: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.5 Germany: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2 France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 France: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4 France: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4.1 France: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.4.2 France: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.5 France: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3 UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 UK: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4 UK: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4.1 UK: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.4.2 UK: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.5 UK: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4 Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4 Italy: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4.1 Italy: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.4.2 Italy: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.5 Italy: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5 Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4 Spain: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4.1 Spain: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.4.2 Spain: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.5 Spain: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6 Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4.1 Rest of Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.4.2 Rest of Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3 Customization:

10.4 Asia Pacific Lymphedema Treatment Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Asia Pacific Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.3 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.4 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.4.1 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.4.2 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.5 Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Country (%)

10.4.6.1 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.3 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.1.4 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.1.4.1 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.1.4.2 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.6.1.5 Japan: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.3 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.2.4 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.2.4.1 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.2.4.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.6.2.5 China: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3 India Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 India: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.3 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.3.4 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.3.4.1 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.3.4.2 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, by Debulking Procedures (US$ Million)

10.4.6.3.5 India: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.3 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.4.4 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.4.4.1 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.4.4.2 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.6.4.5 South Korea: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.5 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.5.1 Overview

10.4.6.5.2 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.5.3 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.5.4 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.5.4.1 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.5.4.2 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.6.5.5 Australia: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.6 Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.6.1 Overview

10.4.6.6.2 Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.4.6.6.3 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

10.4.6.6.4 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

10.4.6.6.4.1 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

10.4.6.6.4.2 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

10.4.6.6.5 Rest of Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.5 Middle East and Africa: Lymphedema Treatment Market

10.5.1 Overview

10.5.2 Middle East & Africa: Lymphedema Treatment Market - Revenue and Forecast to 2028 (US$ Million)

10.5.3 Middle East and Africa: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.5.4 Middle East and Africa: Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.5.4.1 Middle East and Africa: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.4.2 Middle East and Africa: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.5 Middle East and Africa: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6 Middle East and Africa: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

10.5.6.1 Saudi Arabia: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.1 Saudi Arabia: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.2 Saudi Arabia: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3 Saudi Arabia: Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3.1 Saudi Arabia: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.3.2 Saudi Arabia: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.1.4 Saudi Arabia: Lymphedema Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 UAE: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.1 UAE: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.2 UAE: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3 UAE: Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3.1 UAE: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.3.2 UAE: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2.4 UAE: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 South Africa: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.1 South Africa: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.2 South Africa: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3 South Africa: Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3.1 South Africa: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3.2 South Africa: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.4 South Africa: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4 Rest of Middle East and Africa: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.1 Rest of Middle East and Africa: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.2 Rest of Middle East and Africa: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.3 Rest of Middle East and Africa: Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.3.1 Rest of Middle East and Africa: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.3.2 Rest of Middle East and Africa: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.5.6.4.4 Rest of Middle East and Africa: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.6 South and Central America: Lymphedema Treatment Market

10.6.1 Overview

10.6.2 South and Central America: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.3 South and Central America: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.4 South and Central America: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.4.1 South and Central America: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.4.2 South and Central America: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.5 South and Central America: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.6.6 South and Central America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

10.6.6.1 Brazil: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.1 Brazil: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.2 Brazil: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.3 Brazil: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.4 Brazil: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.4.1 Brazil: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.1.4.2 Brazil: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2 Argentina: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.1 Argentina: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.2 Argentina: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.3 Argentina: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.3.1 Argentina: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.3.2 Argentina: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.2.4 Argentina: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3 Rest of South and Central America: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.1 Rest of South and Central America: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.2 Rest of South and Central America: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.3 Rest of South and Central America: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.3.1 Rest of South and Central America: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.3.2 Rest of South and Central America: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

10.6.6.3.4 Rest of South and Central America: Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Lymphedema Treatment Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Lymphedema Treatment Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies by Market Players (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Bio Compression Systems Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Tactile Medical

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Smith & Nephew

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 BSN medical GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Lohmann & Rauscher GmbH & Co. KG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 SIGVARIS GROUP

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ThermoTek

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Huntleigh Healthcare Limited

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 3M Company

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Mego Afek ltd.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Lymphedema Treatment Market, by Condition Type– Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Lymphedema Treatment Market, by Physiological Procedure – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Lymphedema Treatment Market, by Debulking Procedure – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Lymphedema Treatment Market, by Condition Type– Revenue and Forecast to 2028 (US$ Million)

Table 7. US Lymphedema Treatment Market, by Non- Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada Lymphedema Treatment Market, by Non- Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 26. Germany: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 31. France: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36. UK: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 41. Italy: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Debulking Procedures

Table 45. Italy: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

End User

Table 46. Spain: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 51. Rest of Europe: Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Europe: Lymphedema Treatment Market, by Treatment Type– Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Europe: Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Europe: Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 55. Rest of Europe: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 56. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million).

Table 57. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 58. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 59. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 60. Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 61. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 62. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 63. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 64. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 65. Japan: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 66. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 67. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 68. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 69. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 70. China: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 71. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 72. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 73. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 74. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, by Debulking Procedures (US$ Million)

Table 75. India: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 76. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 77. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 78. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 79. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 80. South Korea: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 81. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 82. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 83. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 84. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 85. Australia: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 86. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)

Table 87. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)

Table 88. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)

Table 89. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)

Table 90. Rest of Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 91. Middle East and Africa Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 92. Middle East and Africa Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 93. Middle East and Africa Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 94. Middle East and Africa Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 95. Middle East and Africa Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 96. Saudi Arabia Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 97. Saudi Arabia Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 98. Saudi Arabia Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 99. Saudi Arabia Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 100. Saudi Arabia Lymphedema Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 101. UAE Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 102. UAE Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 103. UAE Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 104. UAE Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 105. UAE Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 106. South Africa Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 107. South Africa Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 108. South Africa Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 109. South Africa Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 110. South Africa Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 111. Rest of Middle East and Africa Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 112. Rest of Middle East and Africa Lymphedema Treatment Market, by Treatment Type – Revenue and Forecast to 2028 (US$ Million)

Table 113. Rest of Middle East and Africa Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 114. Rest of Middle East and Africa Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 115. Rest of Middle East and Africa Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 116. South and Central America Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 117. South and Central America Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 118. South and Central America Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 119. South and Central America Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 120. South and Central America Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 121. Brazil Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 122. Brazil Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 123. Brazil Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 124. Brazil Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 125. Brazil Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 126. Argentina Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 127. Argentina Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 128. Argentina Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 129. Argentina Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 130. Argentina Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 131. Rest of South and Central America Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 132. Rest of South and Central America Lymphedema Treatment Market, by Condition Type – Revenue and Forecast to 2028 (US$ Million)

Table 133. Rest of South and Central America Lymphedema Treatment Market, by Physiological Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 134. Rest of South and Central America Lymphedema Treatment Market, by Debulking Procedures – Revenue and Forecast to 2028 (US$ Million)

Table 135. Rest of South and Central America Lymphedema Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 136. Organic Developments Done by Companies

Table 137. Inorganic Developments Done by Companies

Table 138. Glossary of Terms

LIST OF FIGURES

Figure 1. Lymphedema Treatment Market Segmentation

Figure 2. Lymphedema Treatment Market, By Region

Figure 3. Global Lymphedema Treatment Market Overview

Figure 4. Condition Type Segment Held Largest Share of Type Segment in Lymphedema Treatment Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Lymphedema Treatment Market, by Geography (US$ Million)

Figure 7. Global Lymphedema Treatment Market- Leading Country Markets (US$ Million)

Figure 8. Global Lymphedema Treatment Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Impact Analysis of Drivers and Restraints for Lymphedema Treatment Market

Figure 16. Global Lymphedema Treatment Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Lymphedema Treatment Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Lymphedema Treatment Market

Figure 19. Global Lymphedema Treatment Market, by Condition Type, 2021 & 2028 (%)

Figure 20. Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Global Lymphedema Treatment Market, by Treatment Type 2021 & 2028 (%)

Figure 23. Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34. Global Lymphedema Treatment Market, by End-User, 2021 & 2028 (%)

Figure 35. Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. North America: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 40. North America Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. North America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

Figure 42. Europe: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 43. Europe: Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 44. Europe: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

Figure 45. Germany: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. France: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. UK: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Italy: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Spain: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Rest of Europe: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Asia Pacific Lymphedema Treatment Market Overview, by Country (2021)

Figure 52. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 53. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Country (%)

Figure 54. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 55. China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 56. India: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 57. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 58. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 59. Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. Middle East and Africa: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 61. Middle East & Africa Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 62. Middle East and Africa: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

Figure 63. South and Central America: Lymphedema Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 64. South and Central America Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 65. South and Central America: Lymphedema Treatment Market, by Country, 2021 & 2028 (%)

Figure 66. Impact of COVID-19 Pandemic in North American Country Markets

Figure 67. Impact of COVID-19 Pandemic in European Country Markets

Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 69. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 70. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 71. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Lymphedema Treatment Market

  1. Biocompression Systems
  2. Essity Medical Solutions
  3. L & R Group
  4. SIGVARIS
  5. Tactile Medical
  6. SMITH + NEPHEW
  7. Thermo Tek
  8. Huntleigh Healthcare Limited.
  9. Physiopedia
  10. AIROS Medical, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..